Screener
Fennec Pharmaceuticals FENC Q2 2026 earnings
Reported August 11, 2026 · Before market open
Revenue$17.9MBeat by $1.7M
EPS$0.05Beat by $0.03
Revenue estimate$16.2M
EPS estimate$0.02
Next report
Date not yet announcedVersus estimates
Revenue
Diluted EPS
FAQ
- When did Fennec Pharmaceuticals report Q2 2026 earnings?
- Fennec Pharmaceuticals (FENC) reported Q2 2026 earnings on August 11, 2026 before market open.
- What were Fennec Pharmaceuticals's Q2 2026 revenue and EPS?
- Fennec Pharmaceuticals reported revenue of $17.9M and eps of $0.05 for Q2 2026.
- Did Fennec Pharmaceuticals beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $16.2M by $1.7M. EPS beat the consensus estimate of $0.02 by $0.03.
- How did Fennec Pharmaceuticals's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 85.2% from $9.7M a year earlier.
- Where can I find Fennec Pharmaceuticals's Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001104659-26-095884) directly on SEC EDGAR. The filing index links above go to sec.gov.
